Gelonghui October 24th | Guiyang Xintian Pharmaceutical, Jiangsu Sihuan Bioengineering limit up, Hainan Poly Pharm, Beijing Beilu Pharmaceutical, Huosen Biology and other leading gains.
A股创新药概念活跃 新天药业、四环生物涨停
The concept of innovative drugs in A-shares is active, with Guiyang Xintian Pharmaceutical and Jiangsu Sihuan Bioengineering hitting the daily limit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.